Dr. Frederic Lemay
Claim this profileCentre Hospitalier Universitaire de Sherbrooke-Fleurimont
Studies Colorectal Cancer
Studies Pancreatic Adenocarcinoma
6 reported clinical trials
18 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
MSI-H positive
dMMR positive
2Pancreatic Adenocarcinoma
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Frederic Lemay is currently running
Nivolumab + Ipilimumab
for Colorectal Cancer
The main purpose of this study is to compare the clinical benefit, as measured by Progression-Free Survival (PFS), Objective Response Rate (ORR), and Overall Survival (OS), achieved by nivolumab in combination with ipilimumab or by nivolumab monotherapy in participants with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) metastatic colorectal cancer (mCRC). This study will also compare nivolumab plus ipilimumab combination vs chemotherapy for treatment of MSI-H/dMMR mCRC participants.
Recruiting2 awards Phase 34 criteria
Dostarlimab
for Rectal Cancer
This trial is testing a drug called dostarlimab on patients with a specific type of rectal cancer who haven't been treated before. The goal is to see if this drug alone can treat the cancer effectively, so patients might avoid more aggressive treatments like chemotherapy, radiation, and surgery. Dostarlimab (Jemperli™) has been approved in the EU and USA for treating certain types of cancer.
Recruiting1 award Phase 2
More about Frederic Lemay
Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Frederic Lemay has experience with
- Fluorouracil
- Oxaliplatin
- Leucovorin Calcium
- Nivolumab
- Ipilimumab
- Irinotecan
Breakdown of trials Frederic Lemay has run
Colorectal Cancer
Pancreatic Adenocarcinoma
Microsatellite Instability
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Frederic Lemay specialize in?
Frederic Lemay focuses on Colorectal Cancer and Pancreatic Adenocarcinoma. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are MSI-H positive.
Is Frederic Lemay currently recruiting for clinical trials?
Yes, Frederic Lemay is currently recruiting for 3 clinical trials in Sherbrooke Quebec. If you're interested in participating, you should apply.
Are there any treatments that Frederic Lemay has studied deeply?
Yes, Frederic Lemay has studied treatments such as Fluorouracil, Oxaliplatin, Leucovorin Calcium.
What is the best way to schedule an appointment with Frederic Lemay?
Apply for one of the trials that Frederic Lemay is conducting.
What is the office address of Frederic Lemay?
The office of Frederic Lemay is located at: Centre Hospitalier Universitaire de Sherbrooke-Fleurimont, Sherbrooke, Quebec J1H 5N4 Canada. This is the address for their practice at the Centre Hospitalier Universitaire de Sherbrooke-Fleurimont.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.